(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PEPTIROID

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PEPTIROID

ST13

US500000079316223

Class

5

Filing

79316223

Registration

6776922

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

05/25/2024

Trademark type

Word

Nice classes

5

Filing date

06/11/2021

Registration date

07/05/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/05/2022

Last transaction

07/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

KR

Examiner

MESSICK, TABITHA

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

NOVACELL TECHNOLOGY INC.

Representatives

INVENSYNC Intellectual Property Group

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical agents affecting metabolism; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; wound dressings; pharmaceutical preparations for wounds; pharmacological preparations for skin care; ophthalmic preparations; ocular pharmaceuticals; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for treating allergies; acne treatment preparations; pharmaceutical preparations for the treatment of inflammatory diseases; medicated ointments for treating dermatological conditions; pharmaceutical preparations for the prevention of autoimmune disorders; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for treating asthma; dermatological pharmaceutical products; pharmaceutical products for treating respiratory diseases

Publications

History of USPTO decisions and trademark events.

16 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/25/2024

GPNX

NOTIFICATION PROCESSED BY IB

09/25/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/07/2022

FIMP

FINAL DISPOSITION PROCESSED

09/07/2022

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2022

GPNX

NOTIFICATION PROCESSED BY IB

05/03/2022

PUBO

PUBLISHED FOR OPPOSITION

04/19/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/13/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/13/2022

NPUB

NOTICE OF PUBLICATION

03/30/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2022

DOCK

ASSIGNED TO EXAMINER

03/03/2022

MAFR

APPLICATION FILING RECEIPT MAILED

08/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/22/2021

Continuous trademark protection

Get notified about every new filing that threatens PEPTIROID or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.